Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$19.2M
3 rounds on record
Latest round
$6.5M
Venture round · Aug 2023 · 3 yr ago
Team
22
US Form 5500 (plan participants) · Dec 2025 · +16% in a year
Backers
1
Telegraph Hill Partners
The money's age
Long since its last round
37 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 15 Launched Cell Microsystems Launches Software Supporting 21 CFR Part 11 Compliance, Expanding CellRaft AIR to Regulated Workflows · enterprisenews.com Aug 7, 2024 Launched Cell Microsystems Launches Lab Services for Cell Line and Custom Organoid Development Using Novel CellRaft Technology · fox40.com Feb 7, 2024 Partnership Cell Microsystems and OMNI Life Science Announce Strategic Partnership to Bring Innovative Cellular Analysis Solutions to North America · NewsMedical Aug 23, 2023 Acquisition Cell Microsystems Acquires Fluxion Biosciences to Broaden Cell Analysis Product and Services Portfolio · fox4kc.com Aug 11, 2023 Raised a round Venture round $6.5M · SEC Form D Nov 8, 2021 Raised a round Venture round $12.7M · SEC Form D 2021 Founded Jun 12, 2019 Took on debt financing $1.9M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2023 $6.5M — SEC Form D
Venture round Nov 2021 $12.7M — SEC Form D
Debt Financing Jun 2019 $1.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Cell Microsystems, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Gary PaceExecutive Officer, DirectorSEC Form D
Christopher SimsExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
EditCoFounded 2018
EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell…
Mammoth Biosciences201-500 employees • 1 role
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Alia Therapeutics is a startup which is developing next-generation gene editing medicines to cure genetic diseases.
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
ConceptionVenture round $50k · 2 yr ago • Founded 2018 • 11-50 employees • 4 roles
Conception combines stem cell biology and engineering to create new possibilities for having children.
KytopenVenture round $7.1M · 19 mo ago • Founded 2017 • 51-200 employees
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…

Overview

Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the fields of CRISPR gene editing, cancer research, stem cell biology, immunology and neurobiology.

News

Blog 2 months ago
Your Best CRISPR Clone Might Not Be Your Best Survivor
You've done the hard part: designed your guides, nailed the edit, maybe even high-fived a teammate after confirming it worked. But now comes the part nobody talks about enough-cloning.You need to isolate your edited cells, expand them, and find the clones
Read more
Report
Blog 6 months ago
Unlocking the Secrets of Antibiotic Resistance: How Shear Flow Systems Are Revolutionizing the Fight Against Superbugs
In the ongoing battle against antibiotic-resistant bacteria, or "superbugs," scientists are constantly seeking innovative tools to understand the mechanisms of resistance and develop effective treatments. One such groundbreaking technology is shear flow s
Read more
Report
Blog 10 months ago
Single Cells: Lab Tune Sung to the Rhythm of "Jingle Bells"
By Jessica Hartman, Ph.D.Toiling in the labWith a deadline on its wayTo the scope I goOn a SaturdayI don't see a cloneI've looked for one that's rightWhat misery these data bring,I'll have to look all night,Oh! Single cells, single cells, dilutions aren't
Read more
Report
Blog 10 months ago
Lessons Learned Growing Clones From Over 100 Cell Lines
Historically, cell line development has predominantly relied on a limited number of cell lines such as CHO-K1, HEK293T, and HeLa. However, as biotechnology continues to advance, there is a growing demand for cell line development platforms that can suppor
Read more
Report
Blog 11 months ago
Kite Pharma's Single Cell Cloning Process Improved
The satisfaction that comes from seeing a carefully designed experiment unfold and coalesce into a clue, an answer, or a new tool is what makes research and development so gratifying. But every scientist knows that this process is not always seamless. Whe
Read more
Report
Blog 11 months ago
Why Do Cells Need Each Other?
Single cell workflows are hot topics in scientific research today. The ability to turn a single cell into a viable monoclonal colony is essential for cell line development, recombinant protein, and antibody production, and induced pluripotent stem cell en
Read more
Report
Blog 1 year ago
From Bench to Breakthrough: Organoids Get Real in 3D Suspension Culture
As drug discovery and disease modeling become increasingly sophisticated, 3D cell culture has emerged as a powerful alternative to traditional 2D assays and animal models. In a recent webinar Dr. Allysa Stern showcased how researchers are using the CERO 3
Read more
Report
Blog 1 year ago
Tuning Out the Static: How Dynamic Media Flow is Transforming Cell Cultures
Cell culture is the backbone of modern biomedical research, drug development, and regenerative medicine. Traditionally, cells are grown in static environments-like petri dishes or flasks-where stationary media can lead to inconsistent results. Today, rese
Read more
Report
Show more news

People

Gary Pace
Executive Officer, Director
Christopher Sims
Executive Officer, Director
Nancy Allbritton
Director
Yuli Wang
Director
Matthew Megaro
Director
Rob Capone
Director
Alexander Herzick
Director
Deval Lashkari
Director
Brett Williams
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Durham United States
HQ
Request a Quote or Demo
801 Capitola Drive, Ste 10, Durham, NC 27713
company site
Gary United States
Regional office
Gary Pace, Ph.D., J.D.
801 Capitola Drive, Ste 10, Durham, NC 27713
company site

Financials

Total raised
$21M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $6.5M Details
Venture - Series Unknown 2021 $12.7M Details
Debt Financing 2019 $1.9M Details